Shopping Cart 0
Cart Subtotal
AED 0

Akers Biosciences Inc (AKER) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences Inc (AKER)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Akers Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Akers Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Akers Biosciences Inc, Medical Equipment, Deal Details 11

Partnerships 11

Akers Biosciences Enters into Distribution Agreement with Diagnostica Stago 11

Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12

Akers Biosciences Enters into Distribution Agreement with Aero-Med 13

Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 14

Akers Biosciences Enters into Distribution Agreement with Medline Industries 15

Akers Biosciences Enters into Distribution Agreement with Typenex 16

Equity Offering 17

Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 17

Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 18

Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 19

Akers Biosciences Raises USD0.3 Million in Private Placement of Shares up on Exercise of Warrants 20

Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 21

Akers Biosciences Raises USD6.9 Million in Public Offering of Units 22

Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 24

Akers Biosciences Plans to Raise up to USD3.6 Million in Public Offering of Shares 25

Akers Biosciences to Raise USD2 Million in Private Placement of Shares 26

Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 27

Akers Biosciences Completes Public Offering Of Shares For USD 15 Million 28

Akers Biosciences Inc-Key Competitors 29

Akers Biosciences Inc-Key Employees 30

Akers Biosciences Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Joint Venture 31

Recent Developments 32

Financial Announcements 32

Aug 14, 2018: Akers Biosciences announces Q2 and H1 2018 earnings 32

Jul 13, 2018: Akers Biosciences Announces Q1 2018 Earnings 40

Apr 03, 2018: Akers Biosciences Reports Earnings for Fiscal Year 2017 47

Nov 15, 2017: Akers Biosciences Announces Q3 2017 Earnings 52

Aug 15, 2017: Akers Biosciences: Financial Results for the Six Months Ended June 30, 2017 61

Aug 15, 2017: Akers Biosciences Announces Q2 2017 Earnings 63

Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update 67

May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 68

Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 70

Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 72

Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 76

Corporate Communications 78

Sep 13, 2018: Akers Biosciences: Directorate change-form 8-K filing 78

May 29, 2018: Akers Biosciences Announces Board Change 79

Apr 26, 2018: Akers Biosciences: Directorate Change 80

Sep 07, 2017: Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution 81

Aug 08, 2017: Akers Biosciences Announces Board Changes 82

Legal and Regulatory 84

Jun 29, 2018: Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange 84

May 25, 2018: Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq 85

Product News 86

Apr 24, 2017: Akers Biosciences Updates on Akers Wellness Tests 86

Other Significant Developments 87

Oct 08, 2018: Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update 87

Appendix 89

Methodology 89

About GlobalData 89

Contact Us 89

Disclaimer 89


List Of Figure

List of Figures

Akers Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Akers Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Akers Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Akers Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Akers Biosciences Inc, Medical Equipment, Key Facts, 2017 2

Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Akers Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Akers Biosciences Inc, Deals By Market, 2012 to YTD 2018 9

Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Akers Biosciences Enters into Distribution Agreement with Diagnostica Stago 11

Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12

Akers Biosciences Enters into Distribution Agreement with Aero-Med 13

Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 14

Akers Biosciences Enters into Distribution Agreement with Medline Industries 15

Akers Biosciences Enters into Distribution Agreement with Typenex 16

Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 17

Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 18

Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 19

Akers Biosciences Raises USD0.3 Million in Private Placement of Shares up on Exercise of Warrants 20

Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 21

Akers Biosciences Raises USD6.9 Million in Public Offering of Units 22

Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 24

Akers Biosciences Plans to Raise up to USD3.6 Million in Public Offering of Shares 25

Akers Biosciences to Raise USD2 Million in Private Placement of Shares 26

Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 27

Akers Biosciences Completes Public Offering Of Shares For USD 15 Million 28

Akers Biosciences Inc, Key Competitors 29

Akers Biosciences Inc, Key Employees 30

Akers Biosciences Inc, Subsidiaries 31

Akers Biosciences Inc, Joint Venture 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Akers Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.